Medicare Enrolled
Dr. Anna Milstein, M.D.
Cardiovascular Disease · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Milstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Milstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Milstein
Dr. Anna Milstein is a cardiovascular disease specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Milstein performed 9,066 Medicare services across 5,186 unique beneficiaries.
Between the years covered by Open Payments, Dr. Milstein received a total of $53,556 from 81 pharmaceutical and/or device companies across 1183 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Milstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in CA
$53,556 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,066
Medicare services
Top 7% in CA for cardiovascular disease
5,186
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~477 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,292 | $153 | $210 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,056 | $8 | $15 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
948 | $12 | $68 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
843 | $47 | $60 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
453 | $176 | $378 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
440 | $109 | $159 |
| Annual alcohol misuse screening, 5 to 15 minutes | 421 | $21 | $35 |
| Annual depression screening | 396 | $21 | $49 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
394 | $12 | $44 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
244 | $34 | $75 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
235 | $59 | $114 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
235 | $26 | $75 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
235 | $14 | $35 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
233 | $12 | $35 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
203 | $37 | $47 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
131 | $66 | $91 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
124 | $35 | $150 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
114 | $42 | $200 |
| New patient office visit, complex (60-74 min) | 108 | $185 | $285 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
106 | $174 | $398 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
82 | $29 | $80 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
81 | $70 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $77 | $150 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
66 | $48 | $100 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a nonphysician healthcare professional lasting between 11 and 20 minutes. |
57 | $20 | $45 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
51 | $33 | $35 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
51 | $29 | $30 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
48 | $11 | $38 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
42 | $93 | $200 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
37 | $241 | $310 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
35 | $90 | $250 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
34 | $16 | $35 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
28 | $22 | $55 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
28 | $27 | $50 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
25 | $88 | $200 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
22 | $174 | $383 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
22 | $140 | $250 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
18 | $76 | $320 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
18 | $222 | $343 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $145 | $350 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 17 | $223 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.8% high complexity
11.8% medium
76.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$53,556
Total received (2018-2024)
Avg $7,651/year across 7 years
Top 9% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
1,183
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$31,705 (59.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,851 (40.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,383
2023
$3,658
2022
$8,634
2021
$6,391
2020
$5,132
2019
$11,928
2018
$14,430
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$388
AstraZeneca Pharmaceuticals LP
$285
Merck Sharp & Dohme LLC
$236
ABBVIE INC.
$235
Lilly USA, LLC
$230
Amgen Inc.
$223
Bayer Healthcare Pharmaceuticals Inc.
$219
PFIZER INC.
$193
Janssen Pharmaceuticals, Inc
$169
Novo Nordisk Inc
$134
Lexicon Pharmaceuticals, Inc.
$124
Mallinckrodt Hospital Products Inc.
$74
E.R. Squibb & Sons, L.L.C.
$68
iRhythm Technologies, Inc.
$66
UCB, Inc.
$66
Esperion Therapeutics, Inc.
$64
Paratek Pharmaceuticals, Inc.
$64
AIMMUNE THERAPEUTICS, INC.
$55
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$55
Boston Scientific Corporation
$54
Alnylam Pharmaceuticals Inc.
$51
Edwards Lifesciences Corporation
$42
Takeda Pharmaceuticals U.S.A., Inc.
$41
VIVUS LLC
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Zimmer Biomet Holdings, Inc.
$31
SHIELD THERAPEUTICS INC
$29
GlaxoSmithKline, LLC.
$29
Vifor Pharma, Inc.
$27
CVRx, Inc.
$26
Tactile Systems Technology Inc
$22
Exact Sciences Corporation
$16
Top 3 companies account for 26.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$32,106
Amgen Inc.
$2,072
Amarin Pharma Inc.
$1,982
Novartis Pharmaceuticals Corporation
$1,750
AstraZeneca Pharmaceuticals LP
$1,510
SANOFI-AVENTIS U.S. LLC
$948
Lilly USA, LLC
$873
GlaxoSmithKline, LLC.
$787
Novo Nordisk Inc
$768
ABBVIE INC.
$716
Takeda Pharmaceuticals U.S.A., Inc.
$617
PFIZER INC.
$540
Edwards Lifesciences Corporation
$480
Merck Sharp & Dohme LLC
$473
Boehringer Ingelheim Pharmaceuticals, Inc.
$463
AbbVie Inc.
$406
Bayer Healthcare Pharmaceuticals Inc.
$391
ARBOR PHARMACEUTICALS, INC.
$321
IBSA Pharma Inc.
$311
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$308
E.R. Squibb & Sons, L.L.C.
$283
Bayer HealthCare Pharmaceuticals Inc.
$266
Regeneron Healthcare Solutions, Inc.
$247
Lexicon Pharmaceuticals, Inc.
$231
Esperion Therapeutics, Inc.
$225
Gilead Sciences, Inc.
$225
Relypsa, Inc.
$202
Radius Health, Inc.
$184
Kowa Pharmaceuticals America, Inc.
$172
Arbor Pharmaceuticals, Inc.
$152
FIDIA PHARMA USA INC.
$150
Shield Therapeutics Inc
$148
AbbVie, Inc.
$146
Mallinckrodt Hospital Products Inc.
$146
Horizon Therapeutics plc
$138
Alnylam Pharmaceuticals Inc.
$136
Vifor Pharma, Inc.
$136
Hikma Pharmaceuticals USA
$129
VIVUS LLC
$126
Nestle HealthCare Nutrition Inc.
$121
Paratek Pharmaceuticals, Inc.
$121
Ironwood Pharmaceuticals, Inc
$116
Abbott Laboratories
$113
Biohaven Pharmaceutical Holding Company Ltd.
$105
Boston Scientific Corporation
$105
iRhythm Technologies, Inc.
$96
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$86
Merck Sharp & Dohme Corporation
$84
Eisai Inc.
$82
West-Ward Pharmaceuticals
$82
DePuy Synthes Sales Inc.
$77
Tactile Systems Technology Inc
$74
Actelion Pharmaceuticals US, Inc.
$72
Janssen Biotech, Inc.
$66
UCB, Inc.
$66
IDORSIA PHARMACEUTICALS US INC
$60
Medtronic, Inc.
$55
AIMMUNE THERAPEUTICS, INC.
$55
NESTLE HEALTHCARE NUTRITION INC.
$49
IRONWOOD PHARMACEUTICALS, INC
$48
Daiichi Sankyo Inc.
$48
HeartFlow, Inc.
$47
Allergan Inc.
$41
Baxter Healthcare
$39
Exact Sciences Corporation
$34
Zimmer Biomet Holdings, Inc.
$31
BIOTRONIK INC.
$31
SHIELD THERAPEUTICS INC
$29
Janssen Scientific Affairs, LLC
$29
Medicure Pharma Inc.
$28
CVRx, Inc.
$26
GENZYME CORPORATION
$23
Mylan Specialty L.P.
$23
EISAI INC.
$20
Biohaven Pharmaceuticals, Inc.
$19
Allergan, Inc.
$18
Avanos Medical
$16
SUN PHARMACEUTICAL INDUSTRIES INC.
$15
CMP Pharma, Inc.
$14
Synergy Pharmaceuticals Inc
$14
Purdue Pharma L.P.
$13
Top 3 companies account for 67.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AMVUTTRA · ANORO · ANORO ELLIPTA · AZURE XT DR MRI SURESCAN · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYDUREON · BYSTOLIC · Barostim Neo System · Bimzelx · BodyGuardian · CAMZYOS · COBALT DR MRI SURESCAN · COLOGUARD · COMIRNATY · CREON · Carospir · Cimzia · Cologuard Collection Kit · Corlanor · Creon · Dayvigo · Dexilant · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EVENITY · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Enbrel · FARXIGA · FFRct · Flexitouch Plus · Gel-One Cross-linked Hyaluronate · HYALGAN · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · Hymovis · INVOKANA · Inpefa · JANUVIA · JARDIANCE · KAPSPARGO · KEVZARA · Kerendia · LEQVIO · LICART · LINZESS · LOKELMA · LYRICA · Levemir · Licart · LifeVest · Linzess · Livalo · MONOVISC · MOUNJARO · MULTAQ · Mitigare · Mitra Clip system · Morphabond ER · Movantik · NEXLETOL · NURTEC ODT · NUZYRA · NuDyn · ONPATTRO · OPSUMIT · Otezla · Ozempic · PANCREAZE · PAXLOVID · PEAK · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QUVIVIQ · Quadra Assura CRT Defibrillator · RYBELSUS · Repatha · Rybelsus · SAPIEN 3 Ultra RESILIA · SIMPONI · SPIRIVA RESPIMAT · STELARA · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNTHROID · TALTZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRIVISC SODIUM HYALURONATE · TRULICITY · Tirosint · Trintellix · Trulance · Tymlos · UBRELVY · Uloric · VERQUVO · VIBERZI · VYNDAMAX · VYNDAQEL · Vascepa · Veltassa · Victoza · WATCHMAN · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · Yupelri · ZENPEP · ZIO Patch · ZIO XT Patch · ZYPITAMAG (pitavastatin) · Zio monitor · Zypitamag
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (59%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
585
Per 100K population
5.9
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Milstein is a clinical cardiology specialist, with above-average Medicare volume (top 7% in CA), with speaking/promotional industry engagement in the top 9% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Milstein experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Milstein performed 1,292 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Milstein receive payments from pharmaceutical companies?
Yes. Dr. Milstein received a total of $53,556 from 81 companies across 1,183 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Milstein's costs compare to other cardiologists in Los Angeles?
Dr. Milstein's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Milstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Los Angeles
Browse cardiologists in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology